These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 24732786)

  • 1. Probable Association of an Attack of Bilateral Acute Angle-Closure Glaucoma With Duloxetine.
    Shifera AS; Leoncavallo A; Sherwood M
    Ann Pharmacother; 2014 Jul; 48(7):936-939. PubMed ID: 24732786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral acute angle-closure glaucoma induced by duloxetine.
    Mahmut A; Tunc V; Demiryurek E; Gursoy A
    Ideggyogy Sz; 2017 Sep; 70(9-10):358-360. PubMed ID: 29870629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of treatment patterns and persistence on branded and generic medications in major depressive disorder using retrospective claims data.
    Solem CT; Shelbaya A; Wan Y; Deshpande CG; Alvir J; Pappadopulos E
    Neuropsychiatr Dis Treat; 2016; 12():2755-2764. PubMed ID: 27822048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced Bilateral Secondary Angle-Closure Glaucoma: A Literature Synthesis.
    Murphy RM; Bakir B; O'Brien C; Wiggs JL; Pasquale LR
    J Glaucoma; 2016 Feb; 25(2):e99-105. PubMed ID: 25943730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective serotonin reuptake inhibitors: a review of its effects on intraocular pressure.
    Costagliola C; Parmeggiani F; Semeraro F; Sebastiani A
    Curr Neuropharmacol; 2008 Dec; 6(4):293-310. PubMed ID: 19587851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined phacoemulsification and goniosynechialysis for uncontrolled chronic angle-closure glaucoma after acute angle-closure glaucoma.
    Teekhasaenee C; Ritch R
    Ophthalmology; 1999 Apr; 106(4):669-74; discussion 674-5. PubMed ID: 10201585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure worsening and exacerbation after venlafaxine and duloxetine therapy.
    Colucci VJ; Berry BD
    Ann Pharmacother; 2008 Jun; 42(6):882-7. PubMed ID: 18445706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between serotonin-norepinephrine reuptake inhibitors and acute angle closure: What is known?
    Wiciński M; Kaluzny BJ; Liberski S; Marczak D; Seredyka-Burduk M; Pawlak-Osińska K
    Surv Ophthalmol; 2019; 64(2):185-194. PubMed ID: 30278181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin-norepinephrine reuptake inhibitors for the management of chemotherapy-induced peripheral neuropathy.
    Aziz MT; Good BL; Lowe DK
    Ann Pharmacother; 2014 May; 48(5):626-32. PubMed ID: 24577146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidepressant-selective gynecomastia.
    Kaufman KR; Podolsky D; Greenman D; Madraswala R
    Ann Pharmacother; 2013 Jan; 47(1):e6. PubMed ID: 23324513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aggravation of glaucoma with fluvoxamine.
    Jiménez-Jiménez FJ; Ortí-Pareja M; Zurdo JM
    Ann Pharmacother; 2001 Dec; 35(12):1565-6. PubMed ID: 11793621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
    Favré P
    Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visualization of anterior chamber angle dynamics using optical coherence tomography.
    Leung CK; Chan WM; Ko CY; Chui SI; Woo J; Tsang MK; Tse RK
    Ophthalmology; 2005 Jun; 112(6):980-4. PubMed ID: 15936438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SSRIs and intraocular pressure modifications: evidence, therapeutic implications and possible mechanisms.
    Costagliola C; Parmeggiani F; Sebastiani A
    CNS Drugs; 2004; 18(8):475-84. PubMed ID: 15182218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin noradrenaline reuptake inhibitors: Logical evolution of antidepressant development.
    Montgomery S
    Int J Psychiatry Clin Pract; 2006; 10 Suppl 2():5-11. PubMed ID: 24921676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission of major depressive disorder without adverse events: a comparison of escitalopram versus serotonin norepinephrine reuptake inhibitors.
    Signorovitch J; Ramakrishnan K; Ben-Hamadi R; Yu AP; Wu EQ; Dworak H; Erder MH
    Curr Med Res Opin; 2011 Jun; 27(6):1089-96. PubMed ID: 21438794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Priorities in treating depression only.
    Lam RW
    Int J Psychiatry Clin Pract; 2004; 8 Suppl 1():25-9. PubMed ID: 24930686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Citalopram associated with acute angle-closure glaucoma: case report.
    Croos R; Thirumalai S; Hassan S; Davis Jda R
    BMC Ophthalmol; 2005 Oct; 5():23. PubMed ID: 16202173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of primary angle closure glaucoma management.
    Alipanahi R; Sayyahmelli S
    J Pak Med Assoc; 2011 Jul; 61(7):636-9. PubMed ID: 22204235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined phacoemulsification and viscogoniosynechialysis in patients with refractory acute angle-closure glaucoma.
    Razeghinejad MR
    J Cataract Refract Surg; 2008 May; 34(5):827-30. PubMed ID: 18471641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.